Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Resverlogix Places A BET On RVX-208
Seeking Alpha
Thursday, June 5, 2014 - 11:54am
tags:
RVX-208, Resverlogix, BET-protein inhibitors, atherosclerosis
Senseonics raised $20 million for its continuous glucose monitor and hired ex-Abbott and LifeScan diabetes executive Mirasol Panlilio to lead its sales & marketing team
Mass Device
Thursday, June 5, 2014 - 11:51am
tags:
diabetes, blood glucose monitoring, Senseonics, devices
What You Need to Know About PTC Therapeutics' Promising DMD Drug
Motley Fool
Thursday, June 5, 2014 - 11:19am
tags:
Duchenne Muscular Dystrophy, PTC Therapeutics, eteplirsen
Northwest Bio Fuzzier on Cancer Vaccine Study Patient Enrollment
TheStreet.com
Thursday, June 5, 2014 - 11:18am
tags:
Northwest Biotherapeutics, glioblastoma, DCVax
ASCO: Bristol-Myers Squibb and Merck Don't Disappoint
Motley Fool
Thursday, June 5, 2014 - 11:17am
tags:
ASCO, Merck, Bristol-Myers Squibb, anti-PD-1 immunotherapy, MK-3475
The 3 Biggest Biotech Crashes in May
Motley Fool
Thursday, June 5, 2014 - 9:31am
tags:
Clovis Oncology, INSYS Therapeutics, Aegerion Pharmaceuticals
Three Biotechs That Could Double
Yahoo/Street Authority
Thursday, June 5, 2014 - 9:29am
tags:
Verastem, Versartis, Threshold Pharmaceuticals
The Expected Rise and Inevitable Fall of MannKind
TheStreet.com
Thursday, June 5, 2014 - 9:27am
tags:
MannKind, Afrezza, diabetes, Arena Pharmaceuticals, Belviq
ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?
Yahoo/Benzinga
Thursday, June 5, 2014 - 9:14am
tags:
ASCO, Pfizer, Aromasin, tamoxifen, DARA Biosciences, breast cancer, Herceptin, Tykerb, GSK, Eli Lilly, Bristol-Myers Squibb, Erbitux
Medtronic Said to Evaluate Takeover of Smith & Nephew
Bloomberg
Wednesday, June 4, 2014 - 3:24pm
tags:
Smith & Nephew, Medtronic, M&A, devices
ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted Therapy
Yahoo/Benzinga
Wednesday, June 4, 2014 - 3:20pm
tags:
ASCO, cancer, Imbruvica, JNJ, Eli Lilly, Cyramza
ASCO Meeting Day 1: Preserving Fertility And Reducing Side Effects
Yahoo/Benzinga
Wednesday, June 4, 2014 - 3:18pm
tags:
Fertility, cancer, ASCO, Zoladex, AstraZeneca, Novartis, Zometa
Medicare opens door wide for Gilead's $84K hep C drug Sovaldi
Fierce Pharma
Wednesday, June 4, 2014 - 3:14pm
tags:
Medicare, Gilead, hepatitis C, Sovaldi
AstraZeneca's Crestor gets a boost from Cigna data-crunching deal
Fierce Pharma Marketing
Wednesday, June 4, 2014 - 3:13pm
tags:
AstraZeneca, Crestor, Cigna
Time to Break Up Amgen?
Barron's
Wednesday, June 4, 2014 - 2:55pm
tags:
Amgen
Incyte Gains on Positive Jakafi Data
Yahoo/Zacks.com
Wednesday, June 4, 2014 - 2:53pm
tags:
Incyte, Jakafi, polycythemia vera, ASCO
Bayer Looking to Expand Adempas Label
Yahoo/Zacks.com
Wednesday, June 4, 2014 - 2:50pm
tags:
Bayer, Adempas, pulmonary hypertension
GlaxoSmithKline in $105 mln settlement with U.S. states over marketing
Yahoo/Reuters
Wednesday, June 4, 2014 - 1:40pm
tags:
GSK, Advair, Paxil, Wellbutrin, off-label
Sanofi Targets Counterfeit Viagra Market With OTC Cialis
Bloomberg
Wednesday, June 4, 2014 - 1:39pm
tags:
OTC, Viagra, Cialis, erectile dysfunction, Sanofi
AstraZeneca fights to regain cancer market prominence
Yahoo/Reuters
Wednesday, June 4, 2014 - 9:26am
tags:
AstraZeneca, Pfizer, ASCO

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.